View in EDS

Cancer of unknown primary: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.

Saved in:
Bibliographic Details
Title: Cancer of unknown primary: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.
Authors: Krämer A; Clinical Cooperation Unit Molecular Haematology/Oncology, German Cancer Research Center (DKFZ) Heidelberg, Germany; Department of Internal Medicine V, University of Heidelberg, Heidelberg, Germany., Bochtler T; Clinical Cooperation Unit Molecular Haematology/Oncology, German Cancer Research Center (DKFZ) Heidelberg, Germany; Department of Internal Medicine V, University of Heidelberg, Heidelberg, Germany; Department of Medical Oncology, National Center for Tumor Diseases (NCT), University of Heidelberg, Heidelberg, Germany., Pauli C; Department of Pathology and Molecular Pathology, University Hospital Zurich (USZ), Zurich, Switzerland; Medical Faculty, University of Zurich (UZH), Zurich, Switzerland., Baciarello G; Medical Oncology Department, Azienda Ospedaliera San Camillo Forlanini, Rome, Italy., Delorme S; Division of Radiology, German Cancer Research Center (DKFZ), Heidelberg., Hemminki K; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany; Faculty of Medicine and Biomedical Center, Charles University, Pilsen, Czech Republic., Mileshkin L; Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia., Moch H; Department of Pathology and Molecular Pathology, University Hospital Zurich (USZ), Zurich, Switzerland; Medical Faculty, University of Zurich (UZH), Zurich, Switzerland., Oien K; Institute of Cancer Sciences, University of Glasgow, Glasgow, UK., Olivier T; Department of Oncology, Geneva University Hospital, Geneva, Switzerland; Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, USA., Patrikidou A; Department of Cancer Medicine, Institute Gustave Roussy, University of Paris Saclay, Villejuif, France., Wasan H; Department of Cancer Medicine, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, UK., Zarkavelis G; Department of Medical Oncology, University of Ioannina, Ioannina, Greece., Pentheroudakis G; European Society for Medical Oncology, Lugano, Switzerland., Fizazi K; Department of Cancer Medicine, Institute Gustave Roussy, University of Paris Saclay, Villejuif, France.
Corporate Authors: ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org
Source: Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2023 Mar; Vol. 34 (3), pp. 228-246. Date of Electronic Publication: 2022 Dec 20.
Publication Type: Practice Guideline; Research Support, Non-U.S. Gov't; Journal Article
Journal Info: Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1569-8041 (Electronic) Linking ISSN: 09237534 NLM ISO Abbreviation: Ann Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 36563965
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Cancer of unknown primary: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Krämer+A%22">Krämer A</searchLink>; Clinical Cooperation Unit Molecular Haematology/Oncology, German Cancer Research Center (DKFZ) Heidelberg, Germany; Department of Internal Medicine V, University of Heidelberg, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Bochtler+T%22">Bochtler T</searchLink>; Clinical Cooperation Unit Molecular Haematology/Oncology, German Cancer Research Center (DKFZ) Heidelberg, Germany; Department of Internal Medicine V, University of Heidelberg, Heidelberg, Germany; Department of Medical Oncology, National Center for Tumor Diseases (NCT), University of Heidelberg, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Pauli+C%22">Pauli C</searchLink>; Department of Pathology and Molecular Pathology, University Hospital Zurich (USZ), Zurich, Switzerland; Medical Faculty, University of Zurich (UZH), Zurich, Switzerland.<br /><searchLink fieldCode="AU" term="%22Baciarello+G%22">Baciarello G</searchLink>; Medical Oncology Department, Azienda Ospedaliera San Camillo Forlanini, Rome, Italy.<br /><searchLink fieldCode="AU" term="%22Delorme+S%22">Delorme S</searchLink>; Division of Radiology, German Cancer Research Center (DKFZ), Heidelberg.<br /><searchLink fieldCode="AU" term="%22Hemminki+K%22">Hemminki K</searchLink>; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany; Faculty of Medicine and Biomedical Center, Charles University, Pilsen, Czech Republic.<br /><searchLink fieldCode="AU" term="%22Mileshkin+L%22">Mileshkin L</searchLink>; Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia.<br /><searchLink fieldCode="AU" term="%22Moch+H%22">Moch H</searchLink>; Department of Pathology and Molecular Pathology, University Hospital Zurich (USZ), Zurich, Switzerland; Medical Faculty, University of Zurich (UZH), Zurich, Switzerland.<br /><searchLink fieldCode="AU" term="%22Oien+K%22">Oien K</searchLink>; Institute of Cancer Sciences, University of Glasgow, Glasgow, UK.<br /><searchLink fieldCode="AU" term="%22Olivier+T%22">Olivier T</searchLink>; Department of Oncology, Geneva University Hospital, Geneva, Switzerland; Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, USA.<br /><searchLink fieldCode="AU" term="%22Patrikidou+A%22">Patrikidou A</searchLink>; Department of Cancer Medicine, Institute Gustave Roussy, University of Paris Saclay, Villejuif, France.<br /><searchLink fieldCode="AU" term="%22Wasan+H%22">Wasan H</searchLink>; Department of Cancer Medicine, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, UK.<br /><searchLink fieldCode="AU" term="%22Zarkavelis+G%22">Zarkavelis G</searchLink>; Department of Medical Oncology, University of Ioannina, Ioannina, Greece.<br /><searchLink fieldCode="AU" term="%22Pentheroudakis+G%22">Pentheroudakis G</searchLink>; European Society for Medical Oncology, Lugano, Switzerland.<br /><searchLink fieldCode="AU" term="%22Fizazi+K%22">Fizazi K</searchLink>; Department of Cancer Medicine, Institute Gustave Roussy, University of Paris Saclay, Villejuif, France.
– Name: AuthorCorporate
  Label: Corporate Authors
  Group: Au
  Data: <searchLink fieldCode="CA" term="%22ESMO+Guidelines+Committee%2E+Electronic+address%3A+clinicalguidelines%40esmo%2Eorg%22">ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229007735%22">Annals of oncology : official journal of the European Society for Medical Oncology</searchLink> [Ann Oncol] 2023 Mar; Vol. 34 (3), pp. 228-246. <i>Date of Electronic Publication: </i>2022 Dec 20.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Practice Guideline; Research Support, Non-U.S. Gov't; Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>9007735 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1569-8041 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2209237534%22">09237534 </searchLink><i>NLM ISO Abbreviation: </i>Ann Oncol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=36563965
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.annonc.2022.11.013
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 228
    Titles:
      – TitleFull: Cancer of unknown primary: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Krämer A
      – PersonEntity:
          Name:
            NameFull: Bochtler T
      – PersonEntity:
          Name:
            NameFull: Pauli C
      – PersonEntity:
          Name:
            NameFull: Baciarello G
      – PersonEntity:
          Name:
            NameFull: Delorme S
      – PersonEntity:
          Name:
            NameFull: Hemminki K
      – PersonEntity:
          Name:
            NameFull: Mileshkin L
      – PersonEntity:
          Name:
            NameFull: Moch H
      – PersonEntity:
          Name:
            NameFull: Oien K
      – PersonEntity:
          Name:
            NameFull: Olivier T
      – PersonEntity:
          Name:
            NameFull: Patrikidou A
      – PersonEntity:
          Name:
            NameFull: Wasan H
      – PersonEntity:
          Name:
            NameFull: Zarkavelis G
      – PersonEntity:
          Name:
            NameFull: Pentheroudakis G
      – PersonEntity:
          Name:
            NameFull: Fizazi K
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 03
              Text: 2023 Mar
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-electronic
              Value: 1569-8041
          Numbering:
            – Type: volume
              Value: 34
            – Type: issue
              Value: 3
          Titles:
            – TitleFull: Annals of oncology : official journal of the European Society for Medical Oncology
              Type: main
ResultId 1